Cuorips Inc.
JPX: 4894.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Takayuki Kusanagi
- Employees
- 59
- Headquarters
- Tokyo, Japan
- IPO year
- 2023
- Market cap
- ¥52.4B
- Website
- https://cuorips.co.jp
Loading 4894…
Loading profile data…Frequently asked questions about 4894
What does Cuorips Inc. (4894.T) do?
Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and change...
Where does 4894.T trade?
Cuorips Inc. (4894.T) trades on the Tokyo Stock Exchange.
What sector is 4894.T in?
Cuorips Inc. (4894.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cuorips Inc.?
Takayuki Kusanagi is the chief executive officer of Cuorips Inc. (4894.T).
Where is Cuorips Inc. headquartered?
Cuorips Inc. is headquartered in Japan.
Does 4894.T pay a dividend?
Cuorips Inc. (4894.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4894.T go public?
Cuorips Inc. (4894.T) completed its initial public offering in 2023.